Colectomy with Permanent End Ileostomy Is More Cost-Effective than Ileal Pouch-Anal Anastomosis for Crohn’s Colitis

Digestive Diseases and Sciences

Volumn 61, Issue 2, 2016, Pages 550-559

  Taleban, Sasha ^a,b   Van Oijen, Martijn G H ^c,d   Vasiliauskas, Eric A ^a   Fleshner, Phillip R ^a,f   Shen, Bo ^e   Ippoliti, Andrew F ^a   Targan, Stephan R ^a   Melmed, Gil Y ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e LERNER RESEARCH INSTITUTE   (United States)

^f NONE   (United States)

Author keywords

Colectomy; Colitis; Cost effectiveness; Crohn s disease; Ileostomy; Restorative proctocolectomy

Indexed keywords

AZATHIOPRINE; INFLIXIMAB; ANTIINFLAMMATORY AGENT; GASTROINTESTINAL AGENT;

ADULT; AMBULATORY CARE; ARTICLE; CASE REPORT; COLON RESECTION; COMPARATIVE EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; CROHN DISEASE; DRUG COST; END ILEOSTOMY; HEALTH CARE COST; HUMAN; ILEOANAL ANASTOMOSIS; ILEOSTOMY; ILEUM POUCH; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; PROCTOCOLECTOMY; QUALITY ADJUSTED LIFE YEAR; ANAL CANAL; ANASTOMOSIS; COLOSTOMY BAG; COST BENEFIT ANALYSIS; ECONOMICS; PROCEDURES;

ADULT; ANAL CANAL; ANASTOMOSIS, SURGICAL; ANTI-INFLAMMATORY AGENTS; COLECTOMY; COLONIC POUCHES; COST-BENEFIT ANALYSIS; CROHN DISEASE; GASTROINTESTINAL AGENTS; HUMANS; ILEOSTOMY; MALE;

EID: 84973484063     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-015-3886-3     Document Type: Article

References (37)

1. Caprilli R, Gassull MA, Escher JC, et al. European evidence based consensus on the diagnosis and management of Crohn’s disease: special situations. Gut. 2006;55:i36–i58.
2. Canin-Endres J, Salky B, Gattorno F, Edye M. Laparoscopically assisted intestinal resection in patients with Crohn’s disease. Surg Endosc. 1999;13:595–599.
3. Mekhjian HS, Switz DM, Watts HD, Deren JJ, Katon RM, Beman FM. National Cooperative Crohn’s Disease Study: factors determining recurrence of Crohn’s disease after surgery. Gastroenterology. 1979;77:907–913.
4. Chardavoyne R, Flint GW, Pollack S, Wise L. Factors affecting recurrence following resection for Crohn’s disease. Dis Colon Rectum. 1986;29:495–502.
5. Rungoe C, Langholz E, Andersson M, et al. Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979–2011. Gut. 2013;63:1–10.
6. McClane SJ, Rombeau JL. Anorectal Crohn’s disease. Surg Clin N Am. 2001;81:169–183.
7. Horgan AF, Dozois RR. Management of colonic Crohn’s disease. Probl Gen Surg. 1999;16:68–74.
8. Maykel JA, Hagerman G, Mellgren AF, et al. Crohn’s colitis: the incidence of dysplasia and adenocarcinoma in surgical patients. Dis Colon Rectum. 2006;49:950–957.
9. Fazio VW, Kiran RP, Remzi FH, et al. Ileal pouch anal anastomosis: analysis of outcome and quality of life in 37 patients. Ann Surg. 2013;257:679–685.
10. Le Q, Melmed G, Dubinsky M, et al. Surgical outcome of ileal pouch-anal anastomosis when used intentionally for well-defined Crohn’s disease. Inflamm Bowel Dis. 2013;19:30–36.
11. Melton GB, Fazio VW, Kiran RP, et al. Long-term outcomes with ileal pouch-anal anastomosis and Crohn’s disease: pouch retention and implications of delayed diagnosis. Ann Surg. 2008;248:608–616.
12. Dignass A, Van Assche G, Lindsay JO, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: current management. J Crohns Colitis. 2010;4:28–62.
13. Lichtenstein GR, Hanauer SB, Sandborn WJ. Management of Crohn’s disease in adults. Am J Gastroenterol. 2009;104:465–483.
14. Mowat C, Cole A, Windsor A, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011;60:571–607.
15. Yu AP, Cabanilla LA, Wu EQ, Mulani PM, Chao J. The costs of Crohn’s disease in the United States and other Western countries: a systematic review. Curr Med Res Opin. 2008;24:319–328.
16. Hay JW, Hay AR. Inflammatory bowel disease: costs-of-illness. J Clin Gastroenterol. 1992;14:309–317.
17. Feagan BG, Vreeland MG, Larson LR, Bala MV. Annual cost of care for Crohn’s disease: a payor perspective. Am J Gastroenterol. 2000;95:1955–1960.
18. National Center for Health Statistics. National vital statistics reports, deaths: final data for 2010. http://www.cdc.gov/nchs/data/nvsr/nvsr61/nvsr61_04.pdf. Accessed June 14, 2014.
19. Melmed GY, Fleshner PR, Bardakcioglu O, et al. Family history and serology predict Crohn’s disease after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum. 2008;51:100–108.
20. Colombel JF, Ricart E, Loftus EV Jr, et al. Management of Crohn’s disease of the ileoanal pouch with infliximab. Am J Gastroenterol. 2003;98:2239–2244.
21. Calabrese C, Gionchetti P, Rizzello F, et al. Short-term treatment with infliximab in chronic refractory pouchitis and ileitis. Aliment Pharmacol Ther. 2008;27:759–764.
22. Shen B, Achkar JP, Lashner BA, et al. A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis. 2001;7:301–305.
23. Fichera A, McCormack R, Rubin MA, Hurst RD, Michelassi F. Long-term outcome of surgically treated Crohn’s colitis: a prospective study. Dis Colon Rectum. 2005;48:963–969.
24. Amiot A, Gornet JM, Baudry C, et al. Crohn’s disease recurrence after total proctocolectomy with definitive ileostomy. Dig Liver Dis. 2011;43:698–702.
25. Scammell BE, Andrews H, Allan RN, Alexander-Williams J, Keighley MR. Results of proctocolectomy for Crohn’s disease. Br J Surg. 1987;74:671–674.
26. Muir AJ, Edwards LJ, Sanders LL, et al. A prospective evaluation of health-related quality of life after ileal pouch anal anastomosis for ulcerative colitis. Am J Gastroenterol. 2001;96:1480–1485.
27. Turina M, Remzi FH. The J-pouch for patients with Crohn’s disease and indeterminate colitis: (When) Is it an option? J Gastrointest Surg. 2014;18:1343–1344.
28. Yamamoto T, Watanabe T. Surgery for luminal Crohn’s disease. World J Gastroenterol. 2014;20:78–90.
29. Pemberton JH, Phillips SF, Ready RR, Zinsmeister AR, Beahrs OH. Quality of life after Brooke ileostomy and ileal pouch-anal anastomosis. Comparison of performance status. Ann Surg. 1989;209:620–626.
30. Emblem R, Larsen S, Torvet SH, Bergan A. Operative treatment of ulcerative colitis: conventional proctectomy with Brooke ileostomy versus mucosal proctectomy with ileoanal anastomosis. Scand J Gastroenterol. 1988;23:493–500.
31. Ollendorf DA, Lidsky L. Infliximab drug and infusion costs among patients with Crohn’s disease in a commercially-insured setting. Am J Ther. 2006;13:502–506.
32. Waljee A, Waljee J, Morris AM, Higgins PD. Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut. 2006;55:1575–1580.
33. Shen B, Patel S, Lian L. Natural history of Crohn’s disease in patients who underwent intentional restorative proctocolectomy with ileal pouch-anal anastomosis. Aliment Pharmacol Ther. 2010;31:745–753.
34. Takenaka K, Ohtsuka K, Kitazume Y, et al. Comparison of magnetic resonance and balloon enteroscopic examination of the small intestine in patients with Crohn’s disease. Gastroenterology. 2014;147:334–342.
35. Schwartz DA, Wiersema MJ, Dudiak KM, et al. A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn’s perianal fistulas. Gastroenterology. 2001;121:1064–1072.
36. Park KT, Tsai R, Perez F, Cipriano LE, Bass D, Garber AM. Cost-effectiveness of early colectomy with ileal pouch-anal anastamosis versus standard medical therapy in severe ulcerative colitis. Ann Surg. 2012;256:117–124.
37. Barreiro-de Acosta M, Garcia-Bosch O, Souto R, et al. Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: a multicenter study. Inflamm Bowel Dis. 2012;18:812–817.